Treatment of patients with multifocal motor neuropathy with immunoglobulins in clinical practice: the SIGNS registry

Conclusions:
The management of patients with MMN in everyday clinical practice demonstrates a wide range of absolute dosages and treatment intervals of IG, supporting the recommended practice of determining treatment dose on an individual patient basis. The improvements in muscle strength and reduction in disability, accompanied by increased QoL, strengthen the case for use of IG as a maintenance treatment for MMN.

Source: Therapeutic Advances in Neurological Disorders - March 22, 2016 Category: Neurology Authors: Stangel, M., Gold, R., Pittrow, D., Baumann, U., Borte, M., Fasshauer, M., Hensel, M., Huscher, D., Reiser, M., Sommer, C. Tags: Original Research Source Type: research